Nifty Pharma Weekly Sector Outlook - Aetram Research India - 05.09.2026
Aetram Research India - Nifty Pharma - Weekly Sector Outlook
Aetram Research India - Nifty Pharma - Weekly Sector OutlookNifty Pharma Bears Control Below 26,570; Recovery Above 26,750 May Target 27,000, While 26,450 Signals Further Weakness - 05.09.2026
Current Market Price: 26,480.55
Market Prediction
- Nifty Pharma is undergoing a corrective phase after slipping below its major moving-average cluster. RSI near 36, negative MACD and deeply weak CCI signal persistent downside momentum, while ADX confirms moderate trend strength. Recovery above 26,570 may test 26,750–27,000; below 26,450, risk could expand toward 26,300–26,000 over the coming sessions.
Upcoming Events
- Positive Catalyst: New product approvals and favourable regulatory developments could improve sentiment across pharmaceutical companies.
- Positive Catalyst: Rupee depreciation may strengthen revenue expectations for export-oriented drug manufacturers.
- Negative Catalyst: Adverse regulatory observations or stricter drug-pricing measures could pressure sector valuations and earnings expectations.
Major Support and Resistance
- Support: 26,450, 26,300, 26,000
- Resistance: 26,570, 26,750, 27,000
Volume Analysis
- Recent declines developed with modest volume expansion, indicating increased selling participation near elevated levels. However, the absence of continuous heavy volume suggests orderly profit-taking. Strong participation above 26,570 is needed to revive recovery conviction decisively.
Final Takeaway
- Nifty Pharma retains broader structural support, but immediate momentum remains bearish below 26,570. Oversold indicators may encourage a technical rebound, yet sustained acceptance above 26,750 is necessary to restore directional confidence and reduce downside risk.
Next Week Prediction
- Next week, Nifty Pharma may stay corrective below 26,570; recovery above 26,750 could retest 27,000, while weakness under 26,450 may expose 26,000 during volatile sessions.
Scenario-Based Outlook
- Bullish Scenario: Above 26,570, price may move toward the 26,750–27,000 zone.
- Bearish Scenario: Below 26,450, downside risk toward the 26,300–26,000 zone.
- Neutral Scenario: Between 26,450–26,570, consolidation likely.
Disclaimer: This research report is for informational purposes only. This is not an offer to buy or sell securities. Past performance is not indicative of future results. There is no guarantee of returns. Investments in securities are subject to market risks including loss of capital. Investors should consult their financial advisor before making any investment decisions.
